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Fat contamination of pericardial suction blood and its
influence on in vitro capillary-pore flow properties in
patients undergoing routine coronary artery bypass grafting
Micael Appelblad, ECCP
Gunnar Engstro¨m, MD, PhD
Objective: Neurologic dysfunction after cardiopulmonary bypass might be due to
arterial microembolization. Pericardial suction blood is a possible source of embolic
material. Our aim was to determine the capillary-pore flow ability of pericardial
suction blood.
Methods: Pericardial suction blood from patients undergoing coronary bypass was
collected, and pericardial suction blood and venous blood were sampled at the end
of cardiopulmonary bypass and before reinfusion of pericardial suction blood.
Pericardial suction blood was (n  10) or was not (n  10) prefiltered through a
30-m cardiotomy screen filter before capillary in vitro analysis. Additionally, in 8
patients the plasma viscosity was measured, and in 5 of these patients, pericardial
suction blood capillary deposits were evaluated by using a microscopy-imprint
method and fat staining. Capillary flow was tested through 5-m pore membranes.
Tested components were plasma, plasma-eliminated whole-blood resuspension, and
leukocyte/plasma-eliminated erythrocyte resuspension. Initial filtration rate and
clogging slope expressed the blood-to-capillary interaction.
Results: The plasma-flow profile of pericardial suction blood was highly impaired,
with a 47% reduction in initial filtration rate (P .001) and a 142% steeper clogging
slope flow deceleration (P  .01). This difference was not due to a change in
pericardial suction blood viscosity, such as by free hemoglobin, which corresponded
to 5.7% of the erythrocytes. There were no differences in resuspended whole blood
or erythrocytes. The cardiotomy filter had no effect. Microscopy suggested the
presence of capillary fat deposits in pericardial suction blood that were not seen with
venous plasma (P  .05). The pericardial suction blood volume was 458  42 mL
and contained 95.6  9.3 g/L hemoglobin.
Conclusions: The pericardial suction blood plasma capillary flow function was
highly impaired by liquid fat. Pericardial suction blood hemoglobin appears worth
recovering after fat removal, despite profound hemolysis.
The clinical spectrum of neurologic disorders after cardiac operationsvaries from major stroke to diffuse symptoms detected in sensitivepsychometric tests.1,2 This brain damage has several possible causes.General effects of low blood pressure and cardiopulmonary bypass(CPB) with systemic inflammatory response are plausible, but inaddition, embolic mechanisms are commonly suspected.3 These
embolic sources might either be air bubbles4 or particulate matter.5 They might also
be described in terms of microembolism and macroembolism, which can be the
result of detached particles from a calcified ascending aorta6 or plastic or silicon
material generated from the CPB circuit.7,8 These particles enter the aorta through
the arterial line. Recently, the pericardial suction blood (PSB) has been suggested as
a source of fat-related deposits in the brain capillaries of animals9 and human
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subjects10 after CPB exposure. PSB is contaminated with
cellular and liquid fat from the wound.10 It is further pos-
sible that activated white blood cells and platelets add to this
deterioration.11,12 We aimed to describe the capillary-pore
flow properties of PSB with the hypothesis that fat contam-
ination can be monitored with this technique.
Materials and Methods
Patient Selection
After institutional review board approval, patients undergoing
elective, first-time, routine coronary artery bypass grafting
(CABG) with CPB were enrolled successively as they appeared on
the operation program. Patients were informed and provided writ-
ten consent. Exclusions were ongoing anticoagulant therapy, ap-
parent bleeding disorder, advanced peripheral vascular disease,
and diabetes. In 20 patients the in vitro capillary-pore flow prop-
erties of PSB versus venous blood was measured. In 10 of these
patients, selected in random sequence, the PSB was prefiltered
through a 30-m cardiotomy screen filter. Patient demographics
are presented in Table 1. In addition to these 20 patients, plasma
viscosity of PSB versus venous blood was measured in 8 patients,
and in 5 of these, the capillary membrane deposits of plasma
samples were analyzed by means of microscopy.
Conduct of CPB and Anesthesia
Before CPB, heparin (350 IU/kg) was administered to achieve an
activated clotting time exceeding 480 seconds. The CPB prime
solution consisted of 1400 mL of Ringer acetate, 60 g of mannitol
(both from Fresenius-Kabi, Uppsala, Sweden), 160 mmol of NaCl,
and 7500 IU of heparin (Lo¨vens, Ballerup, Denmark). The CPB
apparatus included a membrane oxygenator with an open-circuit,
integrated, venous cardiotomy, hard-shell reservoir (Quadrox, Jos-
tra Medizintechnik, Hirrlingen, Germany) and a roller pump
(Terumo-Sarns 9000 Perfusion system, Ann Arbor, Mich) set to a
nonpulsatile mode, nonocclusive roller setting, with cold antegrade
crystalloid cardioplegia (St Thomas Hospital II solution with
added procaine hydrochloride), moderate hypothermia, acid base
management after an alpha-stat regimen, and pump flow regulated
to yield a venous saturation of greater than 70%. Proximal coro-
nary anastomoses were performed with a side-biting clamp. An-
esthesia was maintained with intravenous fentanyl, midazolam,
propofol, and pancuronium mixed with inhaled isoflurane.
Collection System of PSB
An emptied 2-L saline bag (Fresenius-Kabi) was interpositioned
between the cardiotomy roller pump and the cardiotomy reservoir.
The vent line was not part of the PSB system. The PSB-containing
TABLE 1. Patient demographics
In vitro subgroups
No cardiotomy filter Cardiotomy filter
Patient data
Sex (male/female) 10/0 9/1
Age (y) 65.3 2.7 65.0 2.3
Length (cm) 173.9 1.1 175.3 2.3
Weight (kg) 76.0 2.0 81.3 4.1
Body surface area (m2) 1.91 0.03 1.98 0.06
Vessel disease (1-3) 2.7 0.2 2.7 0.2
NYHA: I, II, IIIA, IIIB, IV (1-5) 3.3 0.2 3.5 0.2
Left ventricular function (1
[good]-3 [bad])
1.1 0.1 1.2 0.1
Surgical data
Anastomoses (n) 3.2 0.2 3.5 0.2
Surgical time (min) 156.4 16.8 157.4 8.9
CPB time (min) 61.0 5.5 63.6 5.7
Aortic crossclamp time (min) 29.1 2.9 32.5 2.3
PSB volume (mL) 419 53 501 66
Time before reinfusion (min) 48.8 3.9 57.3 4.4
Surgical bleeding (mL) 435 121 500 114
Volume load (mL) 3166 287 3337 153
Minimum temperature (°C) 34.3 0.2 34.4 0.2
Erythrocyte donor use (U/patient) 0.2 0.2 0.1 0.1
Postoperative data
Length of stay (d) 7.1 0.5 8.3 0.9
Patient demographics are shown, subdivided into those in whom the PSB in vitro blood sample was or was not prefiltered through a 30-m cardiotomy
filter. The New York Heart Association scale is converted to a 5-grade scale for statistical simplicity. Left ventricular function was subgrouped into 3
numeric levels. This was according to visual observations by the cardiologists on the left ventricular angiogram or preoperative echocardiography. The
term surgical bleeding denotes non-PSB bleeding in the operating room. Volume load refers to the calculated difference between volume input (crystalloid
and blood products) versus output (eg, urine and bleeding). The temperature was recorded in the urine bladder. Mean  SEM values are given, although
some data are of ordinal scale.
NYHA, New York Heart Association.
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bag was continuously weighed with an analog scale. The density of
PSB was determined to be 1.055 kg/L, and PSB weight was
converted to volume. After the release of the side-biting clamp, the
collected PSB was gently mixed before blood sampling and rein-
fusion. Venous blood and PSB, each in 20-mL samples, were
carefully aspirated from the venous reservoir inlet and from the
PSB collection bag. Identical syringes were used, and the samples
were sent to the laboratory for immediate analysis.
Media
A Krebs-Ringer-HEPES buffer (KRH) was used (NaCl, 135 mmol/L;
KCl, 4.7 mmol/L; KH2PO4, 1.2 mmol/L; and N-2-hydroxyeth-
ylpiperazine-N-2-ethanesulfonic acid, 20 mmol/L) supplemented with
0.02% wt/vol human serum albumin, 5.0 mmol/L glucose, and 2.56
CaCl2. The buffer was prefiltered through a 0.45-m Millipore (Mil-
lipore Corp, Bedford, Mass) membrane and had an osmolality of 300
mosm and a pH of 7.4, which was calibrated by adding NaOH.
Blood Sample Processing for Capillary-Pore Analyses
and Cellular Counts
In the initial 20 patients, PSB and venous blood were processed to
explore their different subcomponents. This process is shown in
Figure 1. In 10 of these samples, the PSB was allowed to drain
through a cardiotomy screen filter. A cardiotomy filter was taken
from inside a standard reservoir (Monolyth VRF 40; Sorin, Salug-
gia, Italy) to accomplish this. This filter is a traditional nylon
30-m screen mesh from which circular pieces (13 mm) were
punched out and mounted in a standard filter holder (Nuclepore
Corp, Pleasanton, Calif). This prefiltering was done without ap-
plying driving force to simulate the spontaneous emptying of PSB
into the cardiotomy reservoir.
From the 20-mL blood sample (venous blood and PSB), 250
L was used for differential blood cell counts (Sysmex SE-9000;
TOA Medical Electronics Co, Kobe, Japan). The remaining blood
was divided into 2 equal parts that were both centrifuged for 10
minutes at 1500g. The plasma fraction was carefully aspirated and
stored separately for capillary-pore flow analysis, and 1.5 mL was
frozen at 86°C for later analysis of free plasma hemoglobin.
After plasma removal, the 2 centrifuged samples differed in that
the buffy coat was either removed or allowed to remain with the
erythrocytes (Figure 1). The 2 blood samples were resuspended in
excess KRH to 50 mL and recentrifuged to wash out remaining
plasma. This centrifugation and resuspension was repeated twice.
In the sample from which the buffy coat had been aspirated, the
remaining contaminating leukocyte cells were absorbed by using a
leukocyte filter (Pall RC 400; Pall Biomedical Inc, Fajardo, NY).
This was because buffy coat aspiration alone only removes about
50% of the leukocytes. This technique was a modified version of
our previous method and is efficient in removing contaminating
leukocytes and the great majority of platelets.13
After washing, the blood cells were resuspended to achieve a
40% hematocrit level. A small sample was centrifuged (10,000g
for 10 minutes) for microhematocrit measurement, which was read
in a microscope. On the basis of this exact cell-volume fraction,
Figure 1. The blood-processing flow chart shows how blood was subdivided into plasma, plasma-eliminated
whole-blood resuspension, and leukocyte/plasma-eliminated erythrocyte resuspension. See text for further details.
KRH, Krebs-Ringer-HEPES buffer; hct, hematocrit.
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the blood was diluted to precisely reach the 5% target hematocrit
level, which is a recommended concentration for capillary-pore
flow analysis.14
Measurement of Capillary-Pore Flow
The experiments were all carried out at room temperature.14
The capillary-pore flow properties of the blood subcomponents
were evaluated by using polycarbonate membranes with a 5-m
nominal pore diameter (pore density, 4.0  105; SN: 113613
Lot: 54M8B46; Nuclepore Corp, Pleasanton, Calif). The filters
were mounted in the KGE flowmeter (ESTRAB, Umeå, Swe-
den; Figure 2), which has been well described elsewhere.15 A
hydrostatic constant driving pressure of 600 Pa was used. A
digital balance (Mettler PM 480 Deltarange; Mettler instru-
mente AG, Greifensee, Switzerland) measurement was contin-
uously acquired by using a standard personal computer. The
onset and termination (3.15 seconds) of the flow was controlled
by the computer through a pneumatic slide valve. The flow was
derived from an accumulated volume at a 7.5-Hz sampling rate,
assuming a 1.0 kg/L density of the low hematocrit resuspension
(approximately 1 mg-1 L). Each filter was calibrated with a
blank run before each blood sample (see flow curve in Figure 3,
upper panel). At flow onset, there is acceleration before a steady
state is reached. The acceleration phase was omitted from the
calculations.15 All presented data refer to the 1- to 3-second
window. At steady state, the flow declines with time as a result
of a gradual occlusion of the pores by particles or rigid cells.
The negative curve slope is an indicator for capillary-occluding
property. The results are presented as relative flow (blood
sample divided by blank medium; Figure 3, lower vs upper
panel) to compensate for filter variations. From a linear regres-
sion of the relative curve, 1 to 3 seconds, the intercept at 1
second expresses the initial filtration rate (IFR). The decline in
relative flow represents the clogging slope (CS). It is important
to emphasize that as plasma was removed and the blood cells
were resuspended in KRH, protein-induced cell aggregation did
not occur in the experiments. The platelets are present in the
plasma sample but are reduced in number to about 30% in the
whole-blood resuspension or near completely eliminated in the
erythrocyte resuspension because they are trapped in the leu-
kocyte prefilter.
Measurements of Viscosity, Free Hemoglobin, and
Microscopy of Capillary Filter Deposits
The blood was sampled as described above, including through
a 30-m cardiotomy screen. The 2 samples were centrifuged
(1500g for 10 minutes), and the plasma fraction was carefully
removed for analysis. Although IFR can be regarded as a
relative viscosity measurement (multichannel capillary-pore
viscometer), these data are difficult to interpret because of
cell/particle-pore interaction. The plasma viscosity was there-
fore measured with a standard capillary tube viscometer
(KIMAX-46460-50; Cannon Instrument Co, State College, Pa).
With this device, the time was recorded during a 3.5-mL plasma
flow through a 50-m diameter and a 75-mm-long capillary
under an average driving pressure of 600 Pa. This was per-
formed at room temperature to mimic the capillary-pore flow
results. The flow time of plasma versus water provided the
Figure 2. Computer-assisted capillary-pore flow device. The flow of medium through a capillary-pore capillary
membrane is driven by constant 600-Pa hydrostatic pressure. The onset and stop is computer controlled with a
pneumatic valve and is synchronized with the data output of accumulated weight from a digital balance.
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relative viscosity. The plasma-free hemoglobin was measured
by means of spectrophotometry (DU 640; Beckman Coulter,
Inc, Fullerton, Calif). The absorbance was measured at 400 and
430 nm (baseline mean) versus 415 nm (hemoglobin). A cali-
bration curve was developed with a blood sample of known
hemoglobin concentration, from which precise and complete
lysis at different concentrations was created by means of resus-
pension in water.
A microscopy method was developed with the aim of demon-
strating the mechanisms behind differences in plasma capillary-
pore flow. The 5-m Nuclepore membrane was mounted in a
13-mm Pop-Top filter holder (Nuclepore Corp), through which 1
mL of plasma was filtered. The membrane deposit was imprinted
on a noncoated microscope glass slide. The imprint was air-dried
for 30 seconds and fixed in 10% formaldehyde in phosphate buffer,
followed by staining without dehydration. The staining had a
hydrophilic-basophilic component (Hematoxylin-Mayer) and a hy-
drophobic fat stain (oil red in 50% isopropanol). After drying, a
cover slip was mounted with gelatin. The occurrence and type of
deposit was evaluated under the microscope. Because the great
majority of deposits consisted of fat-positive material, a 10
objective (Carl Zeiss, Obekochen, Germany) was used to provide
an optimal overview. The slides were coded, and the amounts of
deposits were evaluated with a semiquantitative scale (minimum-
maximum  0-4). The observer was blinded to the slide identity.
Statistics
Analysis for differences between venous blood and PSB was done
with the paired Student t test. Differences between groups of
patients, with and without a cardiotomy filter, were determined by
means of unpaired testing. The results demonstrated a close to
normal distribution. The capillary-pore flow data were evaluated
by using linear regressions with a least-sum square method. The
microscopy data were evaluated by means of exact probability
calculation. Mean  SEM values are given.
Results
Clinical Results
The volume of collected PSB was, on average, 458  42
mL (range, 250-1000 mL). No donor blood was needed
during CPB (surgical data are shown in Table 1).
Blood Cell Characteristics, PSB Versus Venous Blood
The PSB differed from venous blood (Table 2). The 30-m
cardiotomy filter did not affect the PSB cell counts, and in
Table 2 the results were pooled (n  20). The PSB and
venous blood had similar hemoglobin concentrations, and
there were no artifacts from hemodilution. However, the
leukocyte counts showed differences between groups. The
overall numbers were reduced in PSB, which solely reflects
the neutrophilic cells. Platelets were found to be increased
compared with levels seen in venous blood. For compari-
son, the blood cell counts before and after the operation are
also shown (Table 2).
Capillary-Pore Flow Properties of PSB Versus Venous
Plasma
The PSB plasma-flow profile was highly impaired, both in
terms of IFR and CS (Figure 3, upper panel). The flow data
are better expressed on their relative scale versus blank flow
to compensate for filter variations (Figure 3, lower panel;
Table 3). The addition of the 30-m cardiotomy filter did
Figure 3. Flow curves of PSB and venous blood plasma. Upper
panel, The absolute flow rate versus time shows an obvious
acceleration that ends at about 1 second for blank medium. This
period is omitted from the calculations, and all presented data
refer to the measuring window of 1 to 3 seconds. The 2 curves at
the top show the flow curve of buffer (blank flow), whereas that
for venous plasma (open circles) and PSB plasma (open squares)
demonstrate a depressed flow rate. Lower panel, Each sample is
tested versus the blank medium to calculate the relative flow
rate, which is indicated. This is the inverse of relative viscosity,
although this model is more sensitive to suspended particles and
cells. Open and filled circles indicate relative flow of venous
plasma in the 2 study groups without and with 30-m cardiotomy
prefiltering, respectively. Open and filled squares indicate rela-
tive flow of unfiltered PSB plasma and 30-m prefiltered PSB
plasma, respectively. There are 10 observations in each group.
Data points denote mean values  SEM.
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not improve the PSB plasma-flow properties. The IFR at 1
second (Table 3) illustrates the relative effect of plasma in
this model. The plasma-flow properties did not correlate
with plasma platelet counts.
Flow Properties of Resuspended Whole-Blood Cells
(Leukocytes Remaining)
With 5% washed whole-blood cells in suspension, the flow
decreased versus that of plasma (Table 3). There were no
detectable differences between the behavior of venous
blood and PSB (Figure 4). In this setting the leukocytes
have a great effect on the filter-occluding properties, and
leukocyte counts showed a strong inverse association to
flow. The IFR was sensitive to neutrophilic and macrophage
counts (P  .05 and P  .01 for linear correlation, respec-
tively). The CS was sensitive to lymphocyte and platelet
counts (P  .05). The addition of the 30-m cardiotomy
filter appeared to decrease clogging, as indicated by the CS
measurement (P  .05, Table 3).
Flow Properties of Resuspended Erythrocytes
When the buffy coat and remaining leukocytes were re-
moved, the flow of 5% erythrocytes was improved versus
that with the buffy coat remaining. This difference ex-
presses the relative magnitude of leukocyte contribution to
the results, and the CS was reduced (P  .05 and P  .01,
Figures 4 and 5, respectively). PSB did not differ from that
of venous blood, and the 30-m filter did not add detectable
changes (Figure 5). However, when the 2 groups were
pooled (n  20), there was a close-to-significant (P  .06)
steeper CS in PSB, possibly indicating an erythrocyte
trauma.
Plasma-Free Hemoglobin and Viscometry
The PSB had macroscopic hemolysis, and the free hemo-
globin was 5478  479 mg/L compared with 48  7 mg/L
in venous blood (P  .001). The contribution of PSB to the
venous free hemoglobin on reinfusion was calculated, as-
suming a fixed plasma distribution volume of 5 L and an
additional 1.4 L of priming. The PSB and venous hematocrit
and free hemoglobin levels allowed calculation of an ex-
pected free hemoglobin level of 455 mg/L. The PSB there-
fore accounts for about 89% of the measured free hemoglo-
bin at the end of CPB.
The PSB free hemoglobin demonstrated no correlation to
PSB plasma viscosity. The plasma relative viscosity was not
different between PSB and venous plasma (1.35  0.07 vs
1.33  0.06, respectively).
Microscopy Results
The filter imprint revealed deposits of fat-positive staining
in PSB. In the microscopic evaluation the PSB showed
positive results in 5 of 5 experiments (P  .05). In terms of
the semiquantitative scale (0-4 points), the venous plasma
showed an average result of 0.6, and PSB plasma showed
and average result of 3.2 (median, 1 vs 3). Typical deposits
are demonstrated in Figure 6.
Discussion
An undesired outcome of routine cardiac operations is brain
damage, and various risk factors have been identified.16
Despite extensive research, this problem remains without a
definitive solution.1,2,17 A recent concern is the recycling of
PSB. PSB might contribute to the systemic inflammatory
response that occurs after CPB.3 It is known today that PSB
also contains fat from the wound.10 Liquid fat is not a
natural part of blood, which might be exemplified by fat-
resembling microemboli (small capillary and arteriolar di-
lations) found in the small-diameter arteries of the brain
after CPB.9,10
We have previously studied the capillary-pore flow func-
TABLE 2. Differences between venous blood and PSB
Pooled (n  20) paired statistics Venous, before operation Venous, during CPB PSB, during CPB Venous, day 1 ICU
Leukocyte count (109/L) 5.77 0.32 8.08 0.66** 5.88 0.60†† 9.57 0.45***,‡
Neutrophilic cells (109/L) 5.60 0.59 2.84 0.51†††
Eosinophilic cells (109/L) 0.14 0.02 0.57 0.08†††
Basophilic cells (109/L) 0.03 0.01 0.11 0.01††
Lymphocytes (109/L) 2.10 0.14 2.12 0.24
Monocytes (109/L) 0.21 0.03 0.23 0.03
Erythrocyte count (1012/L) 4.95 0.08 3.46 0.17*** 3.17 0.30 3.80 0.09***
Hemoglobin (g/L) 145.8 2.0 97.6 7.0*** 95.6 9.3 112.4 2.6***
Hematocrit (%) 44.2 0.6 30.5 1.6*** 28.1 2.7 34.3 0.8***
Mean cell volume (fL) 89.3 0.6 88.3 0.6*** 88.7 0.6† 90.3 0.7**,‡‡‡
Platelet count (109/L) 206.5 8.3 76.9 7.8*** 104.4 7.2†† 156.3 7.8***,‡‡‡
Cellular counts and concentrations before, during, and after surgical intervention. Both venous blood and PSB are shown during CPB with leukocyte
differential counts. The patients were pooled (n  10  10). Mean  SEM values are given.
Statistical differences are shown with the following symbols: * denotes difference versus preoperative blood, † denotes PSB versus venous blood during
CPB, and ‡ denotes venous blood postoperatively versus venous blood during CPB (single symbol, P .05; double symbol, P .01, triple symbol, P .001).
ICU, Intensive care unit.
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tion of autotransfusion blood and fat contaminants after
knee operations18,19 and found markedly impaired results in
terms of plasma flow. This finding was interpreted as being
caused, in large part, by contaminating particles. After car-
diac operations, mediastinal drain blood is autotransfused
into the venous system, and clogging material might end up
in the pulmonary circulation. However, during cardiac op-
erations and CPB arterial reinfusion, such debris can be
expelled into the cerebral circulation. Furthermore, in a
previous study of ours20 on CPB-induced blood changes, it
was found that leukocytes triggered a marked reduction in
5-m capillary-pore flow. This appeared both as leukocyte
activation but also as a result of leukocytosis during CPB.
Of great interest was the finding that the plasma improved in
capillary-pore flow behavior because of the crystalloid
prime at CPB onset but was then significantly reduced
during CPB. This suggested a mechanism of gradual parti-
cle contamination from the continuously added PSB into the
CPB circuit.
This study is a follow-up to our previous work20 and was
designed to describe the capillary-pore flow properties of
PSB in an in vitro model. For this purpose, PSB was tested
in a specially designed PSB collection system. From a
clinical point of view, this system worked without apparent
effects on CPB management or patient safety. The patients
tolerated this retained volume. The PSB was poor in leuko-
cytes, mainly neutrophilic cells. The hemoglobin concen-
tration was equal to that of venous blood. The mechanisms
behind the neutropenia in the PSB are unknown but can in
theory reflect an activation and adhesion to the wound
tissue.
We used a method to measure the flow of controlled
suspensions of blood through well-defined narrow capil-
lary pores, here of 5 m in diameter and 11 m in length.
These pores and applied methods are well described in
the literature14 and have many clinical implications.21
However, over the years, artifacts have been described,
including by our group.15 Although the experimental
principle might appear simple, the biophysics are com-
plex. However, the method used in this study provided
results that might help in the understanding of how blood
works in human capillaries during CPB and PSB reinfu-
sion. Our initial focus was on PSB leukocytes, and the
method again proved sensitive to leukocytes. However,
the leukocyte contribution to the positive findings was
negligible in comparison with PSB plasma characteris-
tics. When PSB plasma was compared with that of ve-
nous plasma, an obvious deterioration was detected. The
PSB plasma capillary flow indicated a markedly in-
creased capillary clogging ability, and at 3 seconds, the
flow was only about 30% of that for venous plasma and,
in fact, was close to zero in many of the experiments. The
leukocyte flow spectrum was studied by using resus-
pended whole-blood cells, but PSB did not differ from
venous blood in this respect. The erythrocytes were
tested after leukocyte absorption but were also unaf-
fected. One reservation was a close-to-significant steeper
CS slope in PSB erythrocytes, which suggests cellular
trauma. PSB demonstrated major hemolysis, but the non-
lysed cells functioned well. It is important to emphasize
that the blood cells were washed and free from plasma,
and therefore cell aggregation did not occur. The PSB
hemolysis constituted a major portion of free hemoglobin
detected in the circulation, as described by others.22
Another concern that is often recognized is the effect of
platelet activity in CPB systems. The whole-blood frac-
tion of resuspended cells correlated with not only leuko-
cytes (CS) but also with platelet counts (IFR). Platelets
were found in the plasma fraction, but plasma-flow prop-
erties did not correlate with platelet counts. In general,
TABLE 3. Capillary-pore flow data
In vitro blood sample processing
No cardiotomy filter Cardiotomy filter
Venous PSB Venous PSB
Plasma
IFR 0.777 0.022 0.398 0.056*** 0.735 0.021 0.407 0.066***
CS (s1) 0.0551 0.0121 0.1096 0.0090** 0.0376 0.0057 0.1146 0.0144***
Resuspended with leukocytes
IFR 0.550 0.032 0.514 0.039 0.459 0.038 0.498 0.048
CS (s1) 0.1048 0.0108 0.1155 0.0109 0.0924 0.0085 0.0806 0.0105
Resuspended erythrocytes
IFR 0.582 0.034 0.567 0.032 0.578 0.048 0.545 0.048
CS (s1) 0.0644 0.0122 0.0763 0.0106 0.0435 0.0105 0.0655 0.0105
Capillary-pore flow data, IFR and CS are shown for PSB versus venous blood subdivided into plasma, plasma-eliminated whole-blood resuspension, and
leukocyte/plasma-eliminated erythrocyte resuspension groups. The patients were grouped to test the in vitro effects of a 30-m cardiotomy filter versus
without a filter. Mean  SEM values are given (n  10 in each group). Statistical differences are shown between PSB and venous blood in each group
(**P  .01; ***P  .001). Additional statistical results are described in the text.
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platelets have a smaller diameter to that of the in vitro
capillaries used in this model and therefore do not inter-
fere with the results. The effect of a 30-m cardiotomy
filter was also tested, but there was no evidence of
beneficial function in this respect.
The impaired PSB plasma flow can be explained by 2
possible mechanisms: either the viscosity is changed or the
plasma contained contaminating particles. The PSB viscos-
ity was tested but did not demonstrate differences versus the
venous plasma. Contaminating particles were investigated
by means of a newly developed microscopy method. Filter
deposits were imprinted on to a glass slide for fixation and
staining. Two stains were added to examine the possibility
of either basophilic cellular presence, such as platelets and
leukocytes, or hydrophobic material, such as fat. The pres-
ence of fat was clear (Figure 6).
In conclusion, these results support previous findings that
suggested the presence of fat microemboli of PSB.10 This
method might help in the development of new means to
monitor and avoid fat contamination from PSB during CPB.
Although it remains difficult to extrapolate the in vitro
findings to clinical consequences, these findings are of
enough magnitude to strongly question the routine use of
unprocessed PSB.
We thank Mrs Erica Jansson, perfusionist; Mrs Berith Lund-
stro¨m, laboratory technician, for blood sampling and laboratory
assistance; and Dr Michael Haney for language editing.
Figure 4. The relative flow curves of PSB and venous whole-blood
resuspensions with remaining leukocytes. Upper panel, Open
circles and squares indicate flow results without 30-m cardiot-
omy prefiltering of venous and PSB blood cells, respectively.
Lower panel, Filled circles and squares indicate flow results with
30-m cardiotomy prefiltering of venous and PSB blood cells,
respectively. There are 10 observations in each group. Data
points denote mean values  SEM.
Figure 5. The relative flow curves of PSB and venous erythrocyte
resuspensions with eliminated leukocytes. Upper panel, Open
circles and squares indicate flow results without 30-m cardiot-
omy prefiltering of venous and PSB erythrocytes, respectively.
Lower panel, Filled circles and squares indicate flow results with
30-m cardiotomy prefiltering of venous and PSB erythrocytes,
respectively. There are 10 observations in each group. Data
points denote mean values  SEM.
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Figure 6. A typical result from the 5-m filter imprint method: upper panel, venous plasma; lower panel, PSB
plasma. A scale bar is depicted at the bottom right of each panel to indicate 100 m. This PSB-to-venous difference
was seen consistently in 5 of 5 test results.
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